D. E. Shaw & Co. Inc. Purchases 148,902 Shares of Avanos Medical, Inc. (NYSE:AVNS)

D. E. Shaw & Co. Inc. lifted its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 43.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 494,627 shares of the company's stock after purchasing an additional 148,902 shares during the period. D. E. Shaw & Co. Inc. owned 1.08% of Avanos Medical worth $7,874,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in AVNS. EP Wealth Advisors LLC increased its stake in shares of Avanos Medical by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after purchasing an additional 1,289 shares in the last quarter. Cubist Systematic Strategies LLC bought a new stake in Avanos Medical during the fourth quarter valued at approximately $813,000. Bridgeway Capital Management LLC lifted its holdings in shares of Avanos Medical by 87.6% in the 4th quarter. Bridgeway Capital Management LLC now owns 273,251 shares of the company's stock worth $4,350,000 after acquiring an additional 127,591 shares during the last quarter. Brown Advisory Inc. lifted its holdings in shares of Avanos Medical by 12.0% in the 4th quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company's stock worth $30,329,000 after acquiring an additional 204,218 shares during the last quarter. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Avanos Medical in the 4th quarter worth approximately $233,000. Hedge funds and other institutional investors own 95.17% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

Avanos Medical Stock Up 4.9%

NYSE:AVNS opened at $12.75 on Friday. The company has a market capitalization of $589.61 million, a PE ratio of 37.50 and a beta of 1.13. The firm's 50-day moving average price is $13.23 and its 200-day moving average price is $15.81. Avanos Medical, Inc. has a 1-year low of $11.84 and a 1-year high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.07. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The business had revenue of $167.50 million for the quarter, compared to analysts' expectations of $161.75 million. During the same quarter in the prior year, the business earned $0.22 EPS. The business's revenue for the quarter was up .8% compared to the same quarter last year. On average, equities analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Insider Buying and Selling at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of Avanos Medical stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now directly owns 82,047 shares of the company's stock, valued at $1,251,216.75. This trade represents a 7.86% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 2.64% of the company's stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.